advertisement

Barcelona loses Nico, Braithwaite because of health issues

BARCELONA, Spain (AP) - Barcelona midfielder Nico González and forward Martin Braithwaite have been sidelined because of health issues, the Spanish club said Friday.

Nico fractured a toe on his left foot in practice, while Braithwaite tested positive for COVID-19. The club did not say how long they are expected to be out.

Barcelona has only five games left in the season. Then team is fighting for second place in the Spanish league behind Real Madrid, which is a point away from clinching the title.

Barcelona hosts relegation-threatened Mallorca on Sunday at Camp Nou. It has lost three in a row at home in all competitions, something that had never happened before in the same season.

The Catalan club recently also lost American defender Sergiño Dest and playmaker Pedri González because of injuries.

The club also made official the contract extension of Uruguay central defender Ronald Araújo, who will stay until 2026. It had announced an agreement with the player on Tuesday.

The 23-year-old Araújo has scored six goals in 78 appearances with Barcelona.

'œI never doubted that I would stay and I hope to be here for many more years,'ť he said. 'œWe reached an agreement in two meetings. We wanted to do our part to help with the situation that the club is in right now.'ť

___

More AP soccer: https://apnews.com/hub/soccer and https://twitter.com/AP_Sports

Barcelona's Jordi Alba and Nico Gonzalez, right, react after Levante was awarded a penalty shot during a Spanish La Liga soccer match between Levante and Barcelona at the Ciutat de Valencia stadium in Valencia, Spain, Sunday, April 10, 2022. (AP Photo/Alberto Saiz) The Associated Press
Article Comments
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked. If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.